Post event report: Online seminar “Update on the valuation of pharmaceuticals in the Covid-19 world”

e-Projection held an online seminar on September 10th, 2021. This seminar titled “Update on the valuation of pharmaceuticals in the Covid-19 world ” brought together more than 100 representatives from Japanese pharmaceutical companies.   The speaker this time was our CEO, Toshi Nagate and he spoke about the valuation of development project from comprehensive aspect […]


New Drugs Added to NHI Price List on August 12

The Central Social Insurance Medical Council (Chuikyo), an advisory board for the reimbursement system relating to public healthcare insurance, endorsed the listing of 23 new drugs with 15 ingredients at its general meeting on August 4. These new joined the NHI price list on August 12, including Chugai Pharmaceutical’s Evrysdi (risdiplam), which marks the first […]


To Be, or Not to Be in Japan, That is the Problem

Consider involving Japan in your drug development program, and start thinking about it now Globalization in the pharmaceutical industry is an ongoing and never ending process due to the monotonically increasing desire of people all over the world to gain faster access to healthcare innovation, fueled by the tireless efforts of the drug manufacturers to […]


e-Projection is going to BIO Digital 2021!

We will be attending the BIO Digital 2021! Join us next June 10-11 and 14-17 in the virtual space this time, to discuss about your strategy to expand your business globally!! Now more than ever, the world is counting on us to come together to advance innovation and discovery.


To the last drop

Allowing 7 shots per vial of Pfizer’s covid vaccine may wreak havoc to the already problematic Japanese immunization program Mottainai is one of the virtues of Japanese culture which means avoiding waste and making use of all that is available, especially in a country without significant natural resources. Yesterday, this sense of savings was taken […]


Not going viral enough

MSD’s Silgard 9 silently reaches the market after five years of regulatory turmoil and social aversion against immunization While the covid-19 vaccine is the only thing people talk about, last week another type of jab has been launched in the Japanese market. MSD, a multinational pharmaceutical company which is known as Merck and Co. in […]


e-Projection is going to Biotech Showcase Digital 2021!

Join us in the virtual space this time, to discuss about your strategy to expand your business globally.


Exploring the Right Size of Our Team

Last month we were blessed by being joined with two great talents as full-time employees. In just a couple of years, the size of our squad has been rapidly increasing with both members showing full commitment in our operations and key industrial experts among various disciplines joining our advisory board. At the time I embarked […]


Appeal of the Japanese Market

Our publication is referenced in Lacerta Bio’s blog on the Japanese Market. Have We Forgotten About Japan?  


Attending BIO International Conference in Philadelphia

We will be attending the BIO International conference once again, this time in Philadelphia. Join us if you’re also around!